Latest & greatest articles for public health

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on public health or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on public health and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for public health

21. Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study. Full Text available with Trip Pro

Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study. To compare the risk of mortality among people with opioid use disorder on and off opioid agonist treatment (OAT) in a setting with a high prevalence of illicitly manufactured fentanyl and other potent synthetic opioids in the illicit drug supply.Population based retrospective cohort study.Individual level linkage of five health administrative datasets

2020 BMJ

22. Interim guidance: public health management of cases and contacts associated with novel coronavirus (COVID-19) in the community

Interim guidance: public health management of cases and contacts associated with novel coronavirus (COVID-19) in the community Interim Guidance: Public Health Management of cases and contacts associated with novel coronavirus (COVID-19) in the community March 10, 2020 CONTEXT The British Columbia Centre for Disease Control (BCCDC) has adapted the interim guidance from the Public Health Agency of Canada (PHAC) for Regional Health Authorities (RHA) for public health management of human illness (...) of ill arriving or departing international travellers who are suspected of having COVID-19, with the Quarantine Officer notifying local public health authorities. Version: March 10, 2020 1 THE PATHOGEN Coronaviruses have been identified as human pathogens since the 1960s. To date, seven coronaviruses have been shown to infect humans, including COVID-19 ii . Common coronaviruses include OC-43, HKU1, 229E, NL63; these cause illness ranging from common colds to severe respiratory illnesses. Other

2020 CPG Infobase

23. Alcohol licensing: a guide for public health teams

Alcohol licensing: a guide for public health teams Alcohol licensing: a guide for public health teams - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Alcohol licensing: a guide for public health teams Public health teams make sure that licensing policy and applications consider the health and wellbeing of local communities. Published 8 March 2017 Last updated 16 May 2019 — From: Contents This guidance (...) , formally known as the Analytical Support Package, brings together nationally available data and materials with local authority information to support local authorities in accessing and using a range of databases and tools. Local teams are able to input their own data and create interactive maps and reports to help them in their existing role as a responsible authority. Licensing and public health Under the , a number of public bodies known as responsible authorities must be fully notified

2020 Public Health England

24. Gastrointestinal infections: guidance for public health management

Gastrointestinal infections: guidance for public health management Gastrointestinal infections: guidance for public health management - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search The UK has left the EU Guidance Gastrointestinal infections: guidance for public health management (...) Guidance to help professionals in public health and environmental health departments to minimise the risk of transmission of gastrointestinal infections. Published 31 January 2020 From: Documents Ref: PHE publications gateway number: GW-1020 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details This guidance

2020 Public Health England

25. Teaching Information Literacy Skills to Public Health Staff: A Rapid Review

Teaching Information Literacy Skills to Public Health Staff: A Rapid Review Teaching Information Literacy Skills to Public Health Staff A Rapid Review Region of Peel – Public Health Office of the Medical Officer of Health September 16, 2019 Please use the following citation when referencing this document: Region of Peel-Public Health. Teaching information literacy skills to public health staff: A rapid review. Mississauga, ON: Region of Peel – Public Health; 2019. Table of Contents KEY MESSAGES (...) 27 1 Key Messages 1. Both face-to-face and online teaching strategies formats equally increase information literacy (IL) skills. 2. Blended formats do not increase IL skills more than single formats. 3. Students did not express a clear preference for one teaching format. 4. Teaching formats for IL can be adapted to organizational need and context. 2 M Executive Summary Question What are effective strategies for teaching information seeking skills to public health staff? Issue and Context Evidence

2020 Peel Health Library

26. Structure of Public Health

Structure of Public Health 1 Structure of public health: A literature review August 21, 2019 2 Please use the following citation when referencing this document: Region of Peel – Public Health. Structure of public health: A literature review. Mississauga, ON: Region of Peel – Public Health; 2019. 3 1 Issue & Context The 2019 provincial budget proposed substantive changes to the public health sector in Ontario. 1 These include: • Establishing 10 regional public health entities and 10 new regional (...) boards of health (BOHs) with one common governance model by 2020-2021. • Adjusting the provincial-municipal cost-sharing of public health programs. • Streamlining the Ontario Agency for Health Protection and Promotion (Public Health Ontario) to enable greater flexibility with respect to non-critical standards based on community priorities. 1 Currently there are 35 local public health units in Ontario operating under different governance models (e.g., autonomous, regional/municipal, semi-autonomous

2020 Peel Health Library

27. Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany. (Abstract)

Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany. Public health screening for type 1 diabetes in its presymptomatic stages may reduce disease severity and burden on a population level.To determine the prevalence of presymptomatic type 1 diabetes in children participating in a public health screening program for islet autoantibodies and the risk for progression to clinical diabetes.Screening for islet autoantibodies was offered to children aged 1.75 (...) type 1 diabetes, defined by 2 or more islet autoantibodies, with categorization into stages 1 (normoglycemia), 2 (dysglycemia), or 3 (clinical) type 1 diabetes. Secondary outcomes were the frequency of diabetic ketoacidosis and parental psychological stress, assessed by the Patient Health Questionnaire-9 (range, 0-27; higher scores indicate worse depression; ≤4 indicates no to minimal depression; >20 indicates severe depression).Of 90 632 children screened (median [interquartile range {IQR}] age

2020 JAMA

28. Community-centred public health: taking a whole system approach

Community-centred public health: taking a whole system approach Community-centred public health: taking a whole system approach - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Community-centred public health: taking a whole system approach Resources to enable local systems (...) to implement and embed community-centred approaches to health and wellbeing at scale. Published 14 January 2020 From: Documents Ref: PHE publications gateway reference: GW-892 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details Public Health England (PHE) has conducted research into current practice on whole system

2020 Public Health England

29. British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines Full Text available with Trip Pro

British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England Post-Polypectomy and Post-Colorectal Cancer Resection Surveillance Guidelines - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set (...) to Collections Create a new collection Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Gut Actions , 69 (2), 201-223 Feb 2020 British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England

2020 EvidenceUpdates

30. Emerging and re-emerging human infectious diseases: A systematic review of the role of wild animals with a focus on public health impact

Emerging and re-emerging human infectious diseases: A systematic review of the role of wild animals with a focus on public health impact Emerging and re-emerging human infectious diseases: A systematic review of the role of wild animals with a focus on public health impact Cupertino MC, Resende MB, Mayer NA, Carvalho LM, Siqueira-Batista R - Asian Pac J Trop Med Infectious diseases continue to impose unpredictable burdens on global health and economies, a subject that requires constant research (...) new infectious agents with unknown virulent potential. In conclusion, the monitoring of these diseases and adequate preparation for possible epidemics and pandemics are fundamental conditions for the mitigation of their future impact. The zoonotic threat of these etiological agents and the impact on public health can be enormous as shown by the ongoing epidemic of 2019 novel coronavirus (2019- nCoV) infections. "> Impact Factor 2018: 1.772 (@Clarivate Analytics) 5-Year Impact Factor: 1.772

2020 Covid-19 Ad hoc papers

31. Considerations in adjusting public health and social measures in the context of COVID-19

Considerations in adjusting public health and social measures in the context of COVID-19 -1- Considerations in adjusting public health and social measures in the context of COVID-19 Interim guidance 16 April 2020 Background Across the globe, countries have implemented a number of control measures to comprehensively prepare for and respond to COVID-19. The overarching goal of the WHO global COVID-19 response strategy 1 is for all countries to control the pandemic by slowing down transmission (...) and reducing mortality associated with COVID-19, with the ultimate aim of reaching and maintaining a state of low-level or no transmission. Based on local epidemiology, some countries are in the process of scaling up public health and social measures, while others are or currently considering scaling down these measures. Although the goal in all countries is to suppress transmission and provide care for all patients, the intensity of implementation of control measures to achieve this — including

2020 WHO Coronavirus disease (COVID-19) Pandemic

32. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review

Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review Quarantine alone or in combination with other public health measures to control COVID‐19: a rapid review - Nussbaumer-Streit, B - 2020 | Cochrane Library Cookies Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree (...) Cochrane Library features . Scolaris Content Language Banner Portlet Scolaris Content Language Banner Portlet Scolaris Content Display Scolaris Content Display Read comments on this Review(0) Cochrane Clinical Answers Editorials Podcasts Special Collections Quarantine alone or in combination with other public health measures to control COVID‐19: a rapid review Cochrane Systematic Review - Prototype Version published: 08 April 2020 Collapse all Expand all Abstract available in Background Coronavirus

2020 Cochrane

33. What are the highest priority indications for use of serologic testing for COVID-19 clinically and to inform public health efforts?

What are the highest priority indications for use of serologic testing for COVID-19 clinically and to inform public health efforts? COVID-19 Scientific Advisory Group Rapid Response Report April 15, 2020 © 2020, Alberta Health Services, COVID-19 Scientific Advisory Group Key Research Question: What are the highest priority indications for use of serologic testing for COVID-19 clinically and to inform public health efforts? Key Messages from the Evidence Summary • No evidence was identified (...) to inform the clinical or public health implications of serological testing in special populations such as immunocompromised people, critical care patients, or the organ transplantation community. • There was no direct evidence for using serology to inform ‘return to work’ (RTW) policies. However, findings from the immunological and infection dynamics during infection suggest that a combination of RNA testing, IgG testing and IgM testing may help inform RTW decisions for healthcare personnel once

2020 Covid-19 Ad hoc papers

34. Pathogen Genomics in Public Health. Full Text available with Trip Pro

Pathogen Genomics in Public Health. Rapid advances in DNA sequencing technology ("next-generation sequencing") have inspired optimism about the potential of human genomics for "precision medicine." Meanwhile, pathogen genomics is already delivering "precision public health" through more effective investigations of outbreaks of foodborne illnesses, better-targeted tuberculosis control, and more timely and granular influenza surveillance to inform the selection of vaccine strains. In this article (...) , we describe how public health agencies have been adopting pathogen genomics to improve their effectiveness in almost all domains of infectious disease. This momentum is likely to continue, given the ongoing development in sequencing and sequencing-related technologies.Copyright © 2019 Massachusetts Medical Society.

2019 NEJM

35. Policy Recommendations for Public Health Plans to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians. (Abstract)

Policy Recommendations for Public Health Plans to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians. The increasing price of prescription drugs is an ongoing concern for Medicare and Medicaid, particularly for patients with chronic health conditions who are using multiple medications and patients in these programs taking high-priced brand-name specialty drugs. Shifts in benefit design, including higher deductibles and a movement away from (...) copayments to coinsurance, have increased patient out-of-pocket costs and put pressure on program budgets. In this paper, the American College of Physicians expands on its position paper from 2016 and offers additional recommendations to decrease out-of-pocket costs for patients, enhance the government's purchasing power, and address existing policies that add costs to the health care system.

2019 Annals of Internal Medicine

36. New psychoactive substances: challenges for drug surveillance, control, and public health responses. (Abstract)

New psychoactive substances: challenges for drug surveillance, control, and public health responses. The rapid emergence since the mid-2000s of a large and diverse range of substances originally designed as legal alternatives to more established illicit drugs (pragmatically clustered and termed new psychoactive substances; [NPS]) has challenged traditional approaches to drug monitoring, surveillance, control, and public health responses. In this section of the Series, we describe the emergence (...) of NPS and consider opportunities for strengthening the detection, identification, and responses to future substances of concern. First, we explore the definitional complexity of the term NPS. Second, we describe the origins and drivers surrounding NPS, including motivations for use. Third, we summarise evidence on NPS availability, use, and associated harms. Finally, we use NPS as a case example to explore challenges and opportunities for future drug monitoring, surveillance, control, and public

2019 Lancet

37. Hepatitis B: clinical and public health management

Hepatitis B: clinical and public health management Hepatitis B: clinical and public health management - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Register by 26 November to vote in the General Election on 12 (...) December. Guidance Hepatitis B: clinical and public health management Information for healthcare professionals on the diagnosis, prevention and treatment of hepatitis B. Published 31 July 2014 Last updated 5 November 2019 — From: Contents Diagnosis Hepatitis B is a virus that replicates in the liver but is also present at very high levels in the blood of people who are infected. The hepatitis B virus ( ( . When an individual (recipient) is thought to have been exposed to blood from another individual

2019 Public Health England

38. Measles: public health response to cases who have travelled by air whilst infectious

Measles: public health response to cases who have travelled by air whilst infectious Measles: public health response to cases who have travelled by air whilst infectious - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search (...) Register by 26 November to vote in the General Election on 12 December. Guidance Measles: public health response to cases who have travelled by air whilst infectious Guidance about infectious measles on a flight (or international travel) for public health staff, passengers and crew. Published 26 June 2012 Last updated 28 October 2019 — From: Documents Ref: PHE gateway number 2018702 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format

2019 Public Health England

39. Public health implications of legalising the production and sale of cannabis for medicinal and recreational use. (Abstract)

Public health implications of legalising the production and sale of cannabis for medicinal and recreational use. We assess the current and describe possible future public health impacts of the legalisation of cannabis production, sale, and use in the Americas. First, we describe global patterns of cannabis use and their most probable adverse health effects. Second, we summarise evidence regarding the effectiveness of cannabinoids for medicinal use and describe approaches that have been used (...) to regulate the use of medicinal cannabis and how these approaches might have affected medicinal and recreational use and harms (eg, road crashes). Third, we describe how jurisdictions that have legalised recreational use have regulated production and sale of cannabis. Fourth, we evaluate the effects of cannabis legalisation on cannabis use and harms and on the use of alcohol, tobacco, and other drugs. Fifth, we use alcohol and tobacco policy examples to identify possible long-term public health effects

2019 Lancet

40. Frailty: implications for clinical practice and public health. (Abstract)

Frailty: implications for clinical practice and public health. Frailty is an emerging global health burden, with major implications for clinical practice and public health. The prevalence of frailty is expected to rise alongside rapid growth in the ageing population. The course of frailty is characterised by a decline in functioning across multiple physiological systems, accompanied by an increased vulnerability to stressors. Having frailty places a person at increased risk of adverse outcomes (...) , including falls, hospitalisation, and mortality. Studies have shown a clear pattern of increased health-care costs and use associated with frailty. All older adults are at risk of developing frailty, although risk levels are substantially higher among those with comorbidities, low socioeconomic position, poor diet, and sedentary lifestyles. Lifestyle and clinical risk factors are potentially modifiable by specific interventions and preventive actions. The concept of frailty is increasingly being used

2019 Lancet